Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan: the J-HCC Guidelines
Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan: the J-HCC Guidelines
复制标题
DOI：
10.1007/s00535-008-2244-z
复制
发表时间：
2009-01-01
影响因子：
6.3
通讯作者：
Makuuchi, Masatoshi
中科院分区：
文献类型：
--
作者：
Kokudo, Norihiro;Makuuchi, Masatoshi
《肝细胞癌（HCC）临床实践指南》是日本首个基于证据的HCC治疗指南，由日本厚生劳动省支持的专家小组编制。英文译本已经完成（http：//www.jsh.or.jp/），其摘要刚刚出版（Hepatol Res 38：37-51，2008）。这套指南涵盖了六个研究领域：预防、诊断和监测、手术、化疗、经动脉化疗栓塞和经皮局部消融治疗。为了方便用户，还创建了HCC监测和治疗的实用算法，这些算法基于为指南选择的文章的证据，并根据日本医疗实践的现状进行了修改。J-HCC指南出版一年后，在日本的专家和初级保健医生中得到了广泛传播。正如预期的那样，这些指南已经开始应用于HCC临床决策的各个层面。J-HCC准则的第一次修订目前正在进行中，定于2009年3月完成。
The "Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC)," the first evidence-based guidelines for the treatment of HCC in Japan, were compiled by an expert panel supported by the Japanese Ministry of Health, Labour, and Welfare. The English translation has been completed (http://www.jsh.or.jp/), and its summary has just been published (Hepatol Res 38: 37-51, 2008). This set of guidelines covers six research fields: prevention, diagnosis and surveillance, surgery, chemotherapy, transarterial chemoembolization, and percutaneous local ablation therapy. For the users' convenience, practical algorithms for the surveillance and treatment of HCC were also created, which are based on evidence from articles selected for the guidelines and modified according to the current status of medical practice in Japan. One year after their publication, the J-HCC Guidelines have become well disseminated among both specialists and primary care physicians in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision making for HCC. The first revision of the J-HCC Guidelines is now in process, and it is scheduled to be completed by March 2009.